Nexalin Technology Inc (NASDAQ:NXL) does about 1.57M shares in volume on a normal day but saw 765541 shares change hands in the recent trading day. The company now has a market cap of 49.52M USD. Its current market price is $3.85, marking a decrease of -1.28% compared to the previous close of $3.90. The 52 week high reached by this stock is $4.36 whilst the lowest price level in 52 weeks is $0.25.
Nexalin Technology Inc (NXL) has a 20-day trading average at $3.50 and the current price is -11.70% off the 52-week high compared with 1422.94% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.03 and its 200-day simple moving average is $1.34. If we look at the stock’s price movements over the week, volatility stands at 10.79%, which increases to 19.29% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 64.34 to suggest the stock is neutral.
The consensus objective for the share price is $3.00, suggesting that the stock has a potential downside of -28.33% over the period.
The current price level is 9.87%, 89.79%, and 187.26% away from its SMA20, SMA50, and SMA200 respectively, with the NXL price moving below the 50-day SMA on current market day. Nexalin Technology Inc (NXL) stock is down -0.77% over the week and 75.00% over the past month. Its price is 851.09% year-to-date and 1045.83% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.12 and -0.49 for whole year. Expected sales for next quarter are $35k, which analysts say will come at $166k for the current fiscal year and next year at $460k. In addition, estimates put the company’s current quarterly revenue at an average of $30k.
To reach the target analysts have set, the stock logically needs to shrink -28.33 percent from here.
Outstanding shares total 12.86M with insiders holding 23.30% of the shares and institutional holders owning 2.41% of the company’s common stock. The company has a return on investment of -112.04% and return on equity of -135.57%. The beta has a value of 3.73. Price to book ratio is 9.99 and price to sales ratio is 309.50.
